Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare

Core Insights - Vaso Corporation's subsidiary, Vaso Diagnostics, has extended its sales representation agreement with GE HealthCare until December 31, 2030, marking a significant milestone in their partnership that began in May 2010 [1][2]. Group 1: Agreement Details - The amendment allows VasoHealthcare to continue representing GE HealthCare's diagnostic imaging and ultrasound products, including CT, MR, molecular imaging, X-ray, mammography, and interventional guided solutions [2]. - This extension is the fifth time the agreement has been renewed, emphasizing the long-term collaboration and commitment to advancing diagnostic imaging solutions in the U.S. [1][2]. Group 2: Partnership Impact - The collaboration has consistently delivered strong results, improving patient outcomes and supporting healthcare providers in meeting evolving clinical demands [2]. - Both organizations are dedicated to providing cutting-edge technology and exceptional customer support to healthcare providers nationwide [2][3]. Group 3: Leadership Statements - GE HealthCare's President & CEO highlighted the partnership's strength and longevity, emphasizing a shared commitment to advancing patient care in the U.S. [3]. - VasoHealthcare's President expressed that the extension provides customers with continuity and confidence, particularly in serving community hospitals and outpatient imaging centers [4].